Literature DB >> 3536981

Relationship of androgenic activity to splanchnic insulin metabolism and peripheral glucose utilization in premenopausal women.

A N Peiris, R A Mueller, M F Struve, G A Smith, A H Kissebah.   

Abstract

The importance of androgenic activity in mediating the effects of obesity and body fat topography on splanchnic insulin metabolism and peripheral insulin sensitivity was studied in 19 nonhirsute premenopausal women with a wide range of ideal body weight [percent ideal body weight (% IBW), 78-202%] and body fat distribution pattern [waist to hip girth ratio (WHR), 0.67-0.91]. Turnover kinetics of peripheral plasma C-peptide and insulin were measured, and estimates of pancreatic insulin production (PIP) and the hepatic extraction fraction (HEF) were calculated. The peripheral insulin sensitivity index (M/I) was determined during an euglycemic insulin clamp study. Androgenic activity was assessed by estimating the plasma level of sex hormone-binding globulin (SHBG) and percentage of free testosterone (% FT). After iv glucose stimulation, PIP ranged from 40-254 mU/min X m2 and correlated highly with % IBW (r = 0.78; P less than 0.01). Insulin HEF ranged from 5-69% of the pancreatic production and was inversely proportional to WHR (r = -0.60; P less than 0.01). Increasing WHR also correlated with the diminution in M/I (r = -0.47; P less than 0.05), which, in turn, correlated with the decline in the HEF of insulin (r = 0.60; P less than 0.01). Since PIP, HEF, and M/I correlated with SHBG and % FT, and since the degree of androgenic activity correlated with % IBW and WHR, partial regression analysis was performed. After adjusting for the effects of SHBG and % FT, the relationship between % IBW and PIP remained unaltered, whereas the correlation between WHR and HEF or M/I and their relationship to each other were either markedly reduced or became insignificant. Thus, in premenopausal women, the increase in pancreatic insulin production with increasing weight is independent of the degree of androgenic activity. On the other hand, the decline in hepatic insulin extraction and diminution in peripheral insulin sensitivity with upper body fat localization are in part mediated by increased androgenic activity. This association may account for the pronounced hyperinsulinemia and insulin resistance characteristic of this form of obesity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3536981     DOI: 10.1210/jcem-64-1-162

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  18 in total

1.  Increased visceral adipose tissue is associated with increased circulating insulin and decreased sex hormone binding globulin levels in massively obese adolescent girls.

Authors:  M De Simone; A Verrotti; L Iughetti; M Palumbo; G Farello; E Di Cesare; R Bernabei; T Rosato; S Lozzi; S Criscione
Journal:  J Endocrinol Invest       Date:  2001-06       Impact factor: 4.256

2.  Is obesity due to a heritable difference in 'set point' for adiposity?

Authors:  R L Leibel
Journal:  West J Med       Date:  1990-10

3.  The relationships between testosterone, body composition, and insulin resistance: a lesson from a case of extreme hyperandrogenism.

Authors:  Elena Volpi; Steven A Lieberman; Dennis M Ferrer; Charles R Gilkison; Blake B Rasmussen; Manubai Nagamani; Randall J Urban
Journal:  Diabetes Care       Date:  2005-02       Impact factor: 19.112

4.  The effects of race and body fat distribution on insulin sensitivity.

Authors:  F X Pi-Sunyer; H J Dowling
Journal:  Trans Am Clin Climatol Assoc       Date:  1996

Review 5.  Insulin resistance in non-insulin-dependent diabetes mellitus. A review.

Authors:  A A Alzaid
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

6.  Effects of ovary suppression by a long-acting GnRH-agonist on circulating GH, insulin-like growth factor I and insulin levels in women with polycystic ovary syndrome.

Authors:  G Tropeano; I Liberale; I P Vuolo; A Barini; G Caroli; P Carfagna; E Menini
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

Review 7.  Dehydroepiandrosterone and diseases of aging.

Authors:  R R Watson; A Huls; M Araghinikuam; S Chung
Journal:  Drugs Aging       Date:  1996-10       Impact factor: 3.923

8.  Reduction of insulin resistance after correction of nonneoplastic ovarian virilization.

Authors:  M Baldini; E Semprini; A Orsatti; G Viale; L Cantalamessa
Journal:  J Endocrinol Invest       Date:  1993-04       Impact factor: 4.256

Review 9.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

10.  The relative contribution of androgens and insulin in determining abdominal body fat distribution in premenopausal women.

Authors:  R Pasquali; F Casimirri; V Balestra; R Flamia; N Melchionda; R Fabbri; L Barbara
Journal:  J Endocrinol Invest       Date:  1991-11       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.